Continuous infusion of low-dose remifentanil for palliation of pain with Brachial plexus nerve block

Continuous infusion of low-dose remifentanil for palliation of pain with Brachial plexus nerve block - Remifentanil for palliation of pain with Brachial plexus nerve block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039006

Enrollment

Registered

2019-12-26

Start date

2018-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

humerus fracture forearm fracture clavicle fracture shoulder periarthritis rotator cuff tear

Interventions

none of remifentanil 0.02microgram/kg/min of remifentanil 0.05microgram/kg/min of remifentanil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients having elective orthopedic surgery who required general anesthesia and interscalene brachial plexus block.

Exclusion criteria

Exclusion criteria: patients who can not obtain understanding of this study. patients with allergy to remifentanilor other local anesthetic.

Design outcomes

Primary

Measure	Time frame
visual analog scale (VAS) scores for pain after brachial plexus nerve block	—

Countries

Japan

Contacts

Public ContactYoshinori Maeda

Saiseikai Futsukaichi Hospital Department of Anesthesiology

maeyan0222@yahoo.co.jp09053894872

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026